Enhancement of lymphoma cell immunogenicity by infection with nononcogenic virus.
D000406:AKR murine leukemia virus; D000818:Animals; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D002458:Cell Fractionation; D002462:Cell Membrane / Q000276:immunology; D005260:Female; D005620:Freund's Adjuvant / Q000494:pharmacology; D006084:Graft Rejection; D007114:Immunization; D008223:Lymphoma / Q000276:immunology* / Q000382:microbiology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009163:Mycobacterium bovis / Q000276:immunology; D009368:Neoplasm Transplantation; D009522:Newcastle disease virus / Q000276:immunology*; D010534:Peritoneal Neoplasms / Q000276:immunology* / Q000382:microbiology; D018108:Respirovirus / Q000276:immunology*; D014184:Transplantation, Homologous; D014461:Ultracentrifugation; D014779:Virus Replication
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D005620:Freund's Adjuvant